RL
MindMaze Therapeutics Holding S.A.
RLFTY · OTC
$3.14 +0.00% (+$0.00)
Market Cap CHF 54.8M
P/E Ratio -
Div. Yield -
ROE 26.02%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 1.43x
P/S 85.32x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 35.88%
Rev. growth 52.74%
FCF growth N/A
Profitability
20 /100
Weak Net margin 1,542.99%
Op. margin 1,637.85%
FCF margin 1,126.17%
Quality
0 /100
Poor ROE 26.02%
ROA 19.22%
Asset turnover 0.01x
Debt
58 /100
Moderate Current ratio 1.20x
Int. coverage -36.24x
Debt/Equity 0.05x
Stability
1 /100
Unstable Rev. volatility 67.59%
EPS volatility 81.70%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre RLFTY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Zach W. Henderson
Employees
10
Headquarters
Geneva